Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour second Mounjaro injection marks a shift from the unfamiliar to the familiar. By the time you reach it, one week has passed on 2.5mg and your body has begun adjusting to tirzepatide's dual action on appetite and blood sugar regulation. Most people find the second injection feels more routine than the first — you know the steps, you know the sensation, and you're starting to build a read on how your body is responding. That said, the second injection brings its own practical decisions: whether side effects from week one warrant a conversation with your prescriber, whether your injection technique needs any refinement, and whether you're on track to continue. Mounjaro is a prescription-only medicine; every stage of treatment, including this one, sits within a clinical relationship rather than a self-managed routine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is: 'I felt rough after my first injection, is the second one going to be worse?' The honest answer is that for most people, week two is gentler than week one. The most common side effects of tirzepatide (nausea, loose stools, indigestion, tiredness) tend to be most noticeable in the first few days after starting, when the medicine is entirely new to your system. By the second injection, your gut has had a week of exposure, and the pattern often shifts: milder symptoms, shorter duration, or none at all.
That said, 'often' is not 'always'. If your week one was notably difficult, it is worth noting the pattern: did symptoms peak in the first 48 hours and then settle, or did they persist across the full week? Persistent, severe nausea or vomiting that prevents normal eating and drinking is worth reporting before you administer your next dose. The NHS tirzepatide information page sets out which side effects are expected and which require prompt medical attention. Never adjust your dose timing or skip an injection without speaking to your prescriber first.
Appetite changes (eating less, feeling full faster, finding previously appealing foods less interesting) are also common by week two, and these are not side effects to push through; they are part of how the medicine works. Staying well hydrated and eating enough protein matters from the start.
If the first injection felt uncertain (where exactly to hold the pen, how firmly to press, why there was a small mark at the site afterwards) the second is a chance to consolidate technique rather than repeat the same hesitation. The Mounjaro injection uses a KwikPen with a fixed needle; you press it flat against the skin, press the button, and hold for the count recommended in the patient information leaflet. The detail that catches people most is not pressing firmly enough or lifting the pen slightly mid-injection. Both reduce the full dose being delivered.
Rotation matters. If you used your abdomen for injection one, the thigh or upper arm for injection two is the sensible choice. Repeated injections into the same small area can cause skin changes over time. A practical guide to the mechanics and positioning of each site is available in our Mounjaro injection site guide, which covers how to choose and rotate correctly. Using a fresh needle every time is standard; if you have any questions about the right supplies, our needle packs are compatible with the KwikPen.
If your first injection left a bent or damaged needle, do not reuse it and do not attempt the second injection with compromised equipment. Dispose of the needle safely and check our guidance on what to do with a bent Mounjaro needle before proceeding.
The decision to administer your second Mounjaro injection is not purely procedural. It rests on whether week one gave any signals that your prescriber needs to know about. Minor nausea, a passing headache, feeling less hungry: these are not reasons to pause. An allergic reaction, swelling beyond the injection site, severe abdominal pain that radiates to the back, or signs of dehydration from persistent vomiting: these are reasons to contact a clinician before proceeding.
This is the clinical architecture that makes Mounjaro treatment different from taking an over-the-counter supplement. A prescriber who reviewed your consultation is accountable for your ongoing safety, not just your initial approval. The NICE guidance on tirzepatide (TA1026) reflects exactly this expectation: that treatment continues within a supervised framework, with clinical review built in at each stage, and with dose progression tied to how well the treatment is being tolerated.
At nume, every repeat order goes through the same clinical review process as the first, so your prescriber sees your reported experience before treatment continues. Details of how that process works are on our about us page. If something feels off between injections, our aftercare team is available seven days a week, you are not waiting until your next order to raise a concern.
The second injection is also the point at which the practical rhythm of once-weekly treatment becomes clearer. Pick the same day and roughly the same time each week. Some people tie it to a fixed habit, before a weekend morning walk, or on a Monday evening before the week starts. Consistency helps, though if you are a few hours off your usual time it is not a clinical problem; the guidance in the how-to-use guide explains the window for missed or delayed doses.
Storage remains the same: refrigerated at 2–8°C, away from the freezer compartment. The pen should be checked before each injection for clarity and the expiry date. And the sharps disposal routine you started with injection one continues: every used needle goes into a sealed sharps container, never a household bin. Your local council or GP surgery can advise on collection.
For a broader look at what private treatment involves, including how cost is structured, our Mounjaro pricing page covers what is included transparently. If you have not yet started treatment and are weighing your options, speaking to our prescribers is the right first step, the consultation is free and reviewed the same day by a named, GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.